A new study suggests low testosterone levels in low-risk prostate cancer patients could indicate a worsening condition. Robotic prostate surgeon and prostate cancer expert, Dr. Samadi weighs in on the discussion of prostate cancer treatment. Dr. Samadi recommends surgery as the best treatment for prostate cancer and to not fully trust biopsy results as they are random biopsies and are not 100% effective.
After a 23-year-long study, it has been concluded that prostate surgery at the time of a prostate cancer diagnosis, it the better choice over watchful waiting. Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital discussed the findings. Dr. Samadi has performed over 5,600 successful robotic prostate surgeries and stands behind the findings in the treatment of prostate cancer.
World-renowned robotic prostate surgeon, Dr. David Samadi comments on a new study concluding that prostate removal surgery is better than watchful waiting in the treatment of prostate cancer. The study was conducted over 24 years and evaluated the long-term effectiveness of prostatectomy when first diagnosed with prostate cancer.
In light of a new study of prostate cancer treatment, New York robotic prostate surgeon, Dr. David Samadi, discusses the findings. In the debate over prostatectomy vs. the watchful waiting technique, it has been found that prostate removal surgery is more effective in the treatment of prostate cancer. Also discussed is the importance of the PSA test in monitoring for prostate cancer.
David B. Samadi, MD, robotic prostate surgeon and creator of the SMART (Samadi Modified Advanced Robotic Technique) Technique has brought minimally invasive robotic surgery to the Dominican Republic. The HOMS hospital is now home to the David Samadi Robotic Institute. With the opening of this facility, a greater level of prostate cancer treatment has been brought to the Caribbean.
David B. Samadi, MD, world-renowned robotic prostate surgeon is in Dominican Republic at the inauguration of the Hospital Metropolitano de Santiago (HOMS) first robotic surgery unit. The unit was named in honor of Dr. Samadi. After the ribbon cutting, Dr. Samadi performed the first-ever robotic prostate surgery in the Dominican Republic.
New York prostate cancer surgeon and robotics expert, David B. Samadi, MD, joins the Today Show’s Matt Lauer and Al Roker to discuss the importance of prostate cancer screening and the PSA test. Dr. Samadi, Lauer’s long-time urologist, performs prostate exams - DREs (digital rectal exams) - on Matt and Al, demonstrating how quick and painless the test really is. In just 34 seconds Dr. Samadi can detect any irregularities in the prostate.
After a trip to Israel to bring robotic surgery technology and education to the country, Dr. David Samadi returns to follow up on the progress that the country has made in the treatment of prostate cancer. In an emotional discussion, Dr. Samadi talks about how he felt meeting over 400 patients in Tel Aviv, among which were ones that have been cured or are being treated. Also emphasized is the importance of awareness of prostate health as he urges everyone to get the message out, “Get tested, save a life.”
David B. Samadi, MD, highlights the U.S. as inventors and leaders in robotic surgery. He discusses the many international patients who travel to the U.S. looking for the best prostate surgeon. Few international surgeons have the volume of experience and success that, NY robotics expert, Dr. Samadi has. Robotic surgery, he believes, has the power to reverse medical tourism and bring more patients to the U.S. for prostate cancer treatment and cure.
David B. Samadi, MD, explains his custom SMART (Samadi Modified Advanced Robotic Technique) Surgery for prostate cancer. As a NY robotics expert, Dr. Samadi performs a unique form of robotic prostate surgery that targets the cancerous prostate without disrupting the delicate nerves that control erections and urinary control. Urinary continence and sex after prostate surgery are the results for most of Dr. Samadi's patients and their partners.
Robotic prostate surgery, in almost all cases, results in a zero PSA level for life. In this segment, David B. Samadi, MD, addresses the rare incidence of a fluctuating PSA level after prostate removal surgery. Dr. Samadi explains that a PSA rise after surgery could indicate the presence of benign tissue or a cancer recurrence. Elevation timing and speed of change are important factors in assessing the patient’s status. In the case of recurrence, prostate cancer radiation is an effect secondary treatment. Dr. Samadi invites all men newly diagnosed with prostate cancer to contact him for a secondary consultation.
Ovarian cancer, a silent killer, is often diagnosed very late. New research suggests that ovarian cancer cells have a volatile smell that can be detected by dogs. Early diagnosis of ovarian cancer could significantly improve ovarian cancer survival rates. Dr. Samadi discusses similar studies where dogs detected melanoma and lung cancer, suggesting that they could be used to detect other cancers in the future.
Prostate, breast, lung and thyroid cancers are among most frequently over-diagnosed cancers. Experts suggest change in cancer definition to avoid needless radiation, testing and over treatment.
Dr. David Samadi and the Lenox Hill Prostate Cancer Center team are dedicated to ensuring that men enjoy sex after prostate cancer and urinary control after robotic prostate surgery.
The FDA has launched an investigation into the Da Vinci surgical system amid growing concerns over the rising rates of robotic surgery complications. Dr. David Samadi leading robotic prostate surgeon joins the Fox News team to defend the robot. Having performed over 4,500 successful robotic prostate surgeries, Dr Samadi feels the real concern should be the lack of experienced surgeons who are using the robotic platform. Dr. David B. Samadi is Vice Chairman for the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at the the Mount Sinai Medical Center in New York.
With a new investigation underway into the safety of the Da Vinci Surgical system many people are nervous about going under the robotic knife. Dr Samadi, one of the worlds leading robotic prostate surgeons and has performed over 5,600 successful robotic prostate surgeries using this Da Vinci Surgical System and believes that inexperience on the part of the surgeon is the primary factor in these select cases.
Dr David Samadi, leading robotic prostate surgeon and Chief of Robotic Surgery at Lenox Hill Hospital in New York appears on Fox 5 to discuss concerns from the FDA over the Da Vinci Surgical System. Dr Samadi has performed over 4,500 successful surgeries using the Da Vinci Surgical System and believes the only concern patients should have is the experience of their surgeon.
Dr Samadi shares his thoughts on a new miracle drug discovered in the ongoing fight against cancer. CD47 is a hormone secreted by cancer cells that allows them to move through the body without being attacked by our immune system. A new drug prevents this secretion and gives our immune system the chance to fight back. While no human trials have been done, successful trials in mice look extremely promising.
Dr Samadi appears on NewsMax Health to talk about the side effects of traditional prostate cancer surgery. With a traditional surgical approach the patient is much more likely to require transfusions for blood loss and experience incontinence and impotence. The advantage of a robotic surgery is its minimally invasive nature and that is further maximized by the experience of the surgeon.
Dr Samadi appears on Fox News to talk about recent advances in drug design and development. With the success of the human genome project our understanding of the human body is better than ever allowing drug makers to more accurately design new medication.
Dr. David Samadi, leading robotic prostate surgeon, appears on Fox Business News to discuss the use of robotics in the ever evolving practice of medicine...
Dr. Samadi appears on Fox News to discuss the implications of a new study that suggest prostate cancer is being over-treated...
Dr. Samadi appears on Fox News to talk about the recent advances in robotic surgery and how they benefit women in particular. Being a world renowned robotic surgeon Dr. Samadi shares his insight and experience into robotic assisted surgeries, their benefits and potential future applications.
Leading robotic prostate cancer surgeon Dr. David Samadi appears on Fox News to discuss new developments in the diagnosis and treatment of prostate cancer...
Dr. David Samadi appears on News Max Health to discuss the wait and see approach and what it means for those suffering from prostate cancer.
Dr. Samadi discusses his SMART Robotic Surgery treatment and the benefits over open prostate surgery.
Dr. David Samadi, a leading prostate cancer specialist and robotic surgeon, discusses the benefits of robotic prostatectomy surgery on Fox 5 News. Robotic surgery is becoming more common as a treatment method for prostate cancer due to the benefits it potentially has over traditional open and laparoscopic surgical methods. These advantages include less blood loss during surgery with no need for a blood transfusion, smaller incisions that heal quickly lowering the risk of infection, high rates of the return of sexual potency after surgery, and very high rates for regaining continence after surgery.
Dr. David Samadi discusses the benefits of robotic-assisted prostate cancer surgery on Good Day New York. Also referred to as a robotic prostatectomy, the surgery treats prostate cancer by removing the prostate from the patient's body.
Dr. Samadi highlights the benefits of robotic prostatectomy surgery over radiation for prostate cancer. A study from Memorial Sloan Kettering showed a 65 percent reduced risk of prostate cancer metastasis after surgery compared to radiation.
Top robotic prostate cancer surgeon, Dr. David Samadi, breaks down the most important reasons to choose robotic surgery for prostate cancer. He explains that removing the prostate through robotic prostatectomy involves the complete removal of all prostatic tissue and lymph nodes.
The nation’s top prostate cancer surgeon, Dr. David Samadi, comments on newly released data regarding prostate surgery outcomes. The study from Canada indicates that men who underwent prostate surgery in the past could be at risk for a follow continence procedure.
A patient, a surgeon, and a robot walk into the operating room -- but it's no joke. With prostate cancer as the punch line, preserving erectile function and enjoying sex after prostatectomy surgery is no laughing matter.
Robotic prostate surgeon, Dr. David Samadi gives a glimpse into one man's choice to have robotic prostatectomy surgery following his early prostate cancer diagnosis.
Robotic prostate removal surgery is the only procedure that gives complete information about how much prostate cancer is present, what the margins are, and the status of the lymph nodes and seminal vesicles. Seed radiation, beam radiation, HIFU, and cryogenics do not provide these details about prostate cancer.
Patients recovering from prostate cancer deserve the quality of life trifecta, says Dr. David Samadi, leading prostate cancer expert. Robotic prostatectomy surgery delivers on the three most important prostate cancer recovery factors: 1) prostate cancer free, 2) urinary continence, and 3) active sex life.
Dr. Samadi promotes the benefits of a team when it comes to medical expertise.
Part 2, Dr. David Samadi appears at the Times Center for "Surgeons at the Forefront" talking about his revolutionary SMART robotic prostate surgery and answering questions.
Leading robotic prostate cancer surgeon, Dr. David Samadi, comments on study from Duke University regarding the comparison of surgical outcomes from robotic prostatectomy surgery and traditional, open surgery. Dr. Samadi points out that the study involved few patients at an institution with lower surgical volume and unknown levels of surgeon expertise.
Dr. Samadi explains that since testosterone is the fuel that drives prostate cancer, the key to treating it in the advanced stages where surgery is no longer feasible, is to use hormone therapy to cut the production of testosterone. He goes on to mention a new study coming out of Sweden in which 30,000 men were administered such treatments and results showed that over 40% of them went on to suffer either a heart attack or a stroke. Samadi also added that low insulin and diabetes were among other cardiovascular conditions found to be elevated in such cases.
Dr. David Samadi, leading robotic prostatectomy surgeon, joins Dr. Marc Siegel to discuss new research supporting the benefits of undergoing robotic prostate cancer surgery at teaching hospitals. Data reviewed indicates fewer complications, less blood loss and better outcomes than non-academic hospitals.
Robotic prostatectomy expert, Dr. David Samadi discusses the concerning link between prostate cancer hormone therapy and an increased risk of stroke and heart disease. Stressing the importance of early diagnosis through PSA screening, Dr. Samadi explains that radiation and androgen deprivation therapy are used to treat patients with advanced prostate cancer. By lowering testosterone levels hormone therapy can delay the progressions of prostate cancer. However, reduced testosterone levels are linked to higher risk of heart attack, stroke, diabetes, and other serious medical issues.
Dr. Samadi, leading prostate cancer surgeon, continues to stress the importance and efficacy of prostate cancer PSA screening. Despite government health panel recommendations to the contrary, Dr. Samadi urges men to continue with annual PSA tests and discuss the results with their doctors, in conjunction with risk factor analyses. While not all elevated PSA levels indicate prostate cancer, Dr. Samadi believes the testing is invaluable in diagnosing prostate cancer. Acknowledging concerns over urinary and sexual function risks of surgery, he believes the medical community must concentrate efforts on improving surgical outcomes by bettering surgeon expertise.
Dr. David Samadi, Vice Chairman of the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, sits down with Dr. Marc Siegel for discussion on the role of surgeon expertise in treating prostate cancer and cardiac disease. Their conversation includes mention of former President Bill Clinton’s cardiac surgery in 2010 and the fact that cancer and heart disease are the leading causes of death in the United States.
Dr. Samadi discusses the recent prostate cancer diagnoses of prominent politicians in the news. He also briefly discussed healthcare reform and reminded the audience it is Prostate Cancer Awareness month, advising men to get regular screenings.
Dr. David B. Samadi, New York robotic prostate surgeon, appeared on Fox and Friends to discuss the importance of prostate awareness and the different types of prostate cancer treatments available to patients including robotic surgery.
Dr. Samadi is featured on Fox and Friends to discuss robotic prostate surgery, prostate cancer screening tests, and new prostate cancer vaccine.
CBS 2 talks to the leader in the field of robotic surgery about a revolutionary new prostate cancer treatment. Prostate Cancer is now one of the most common cancer in American men. Men facing prostate surgery usually have a traditional operation, which involves large incisions and a long recovery time. New, less traumatic alternative for treating and removing prostate is available...
Drs. David Samadi and Mark Siegel discuss new healthcare reform policies being considered by the Obama administration and the implications for many medical procedures that are provided to people and paid for by government programs. For example, robotic prostate surgery, a procedure that is performed by highly skilled surgeons, like Dr. Samadi, will be reviewed by an independent Medicare Advisory Board that will consider if the procedure is necessary or unnecessary based on the review of general treatment outcome data and overall costs. It's unclear if the Board will consider the performance of individual surgeons and health care providers in its decision to pay for robotic prostate cancer surgeries in the future.
Over 200,000 American men are diagnosed with prostate cancer each year. The New England Journal of Medicine has just released a new study showing the long-term benefits of two different common methods of prostate cancer treatment, watchful waiting and surgical prostate removal (most commonly done now through a procedure called a robotic prostatectomy).
Along with survival, the quality of care and quality of life are equally important for men, who have been diagnosed with prostate cancer. We are now able to provide cancer cure, quality of care, and quality of life, which includes sexual function and continence, using da Vinci robotic surgery.
Surviving cancer is not just a physical challenge, it’s a mental one as well. For prostate cancer new procedures speed healing time, which can be crucial to getting back to normal routines. One of our runners today had the procedure recently. Here is his story…
Robotic Laparoscopic surgery is a less invasive and less dramatic alternative to traditional surgery. This revolutionary and advanced prostate cancer treatment method profoundly reduces blood loss, pain, recovery time, and the familiar unwanted side effects of other treatments..
Prostate cancer is a second leading cause of cancer of cancer just in men. It’s a serious problem with surgery as the only treatment option to completely remove the gland along with the cancer. But now patients have a choice: traditional open surgery or robotic prostate removal. It’s a medical advancement that doctors and patients consider to be the future of prostate cancer treatment